# Comparable performance of 3D and 2D anterior segment optical coherence tomography in predicting intraocular pressure reduction following cataract surgery

**Authors:** Sunee Chansangpetch, Phichayut Phinyo, Jayanton Patumanond, Janejit Choovuthayakorn, Shan C Lin

PMC · DOI: 10.1371/journal.pone.0345582 · PLOS One · 2026-03-25

## TL;DR

This study compares 3D and 2D optical coherence tomography in predicting eye pressure reduction after cataract surgery, finding both methods perform similarly.

## Contribution

Demonstrates comparable predictive performance of 3D and 2D AS-OCT in forecasting IOP reduction after cataract surgery.

## Key findings

- 3D and 2D AS-OCT models showed similar moderate predictability (R² ~36-38%) in the overall cohort.
- Non-glaucoma eyes had higher predictability (R² 53%) with both 3D and 2D models.
- AS-OCT parameters improved IOP prediction over preoperative IOP alone in all groups.

## Abstract

To develop predictive models using three-dimensional (3D) and conventional two-dimensional (2D) anterior-segment optical coherence tomography (AS-OCT) parameters for intraocular pressure (IOP) reduction following phacoemulsification in glaucoma and non-glaucoma cohorts.

This prospective study included patients with and without glaucoma who underwent phacoemulsification. Preoperative predictors of 1-month IOP reduction, including clinical, ocular biometry, and AS-OCT (CASIA2) parameters, were analyzed. 3D AS-OCT measurements were assessed in two approaches: (1) averaging 360-degree values and (2) estimating circumferential areas or volumes. 2D variables were obtained from horizontal cross-sectional images. Model selection with least absolute shrinkage and selection operator (LASSO) for 2D and 3D variables was performed separately. R-squared (R²) used to represent model accuracy. The performance was validated by bootstrap resampling.

A total of 130 eyes (64 glaucoma, 66 non-glaucoma) from 103 patients were included. The average IOP change was −1.20 ± 3.29 mmHg. Preoperative IOP (preIOP) was the strongest single predictor across all models. In the entire cohort, the final models showed moderate predictability (R² 38% for 3D and 36% for 2D; optimism-corrected R² 31% for both). In glaucoma eyes, models incorporating AS-OCT angle status and anterior chamber width achieved R² values of 36% (3D) and 38% (2D), with optimism-corrected R² of 27% (3D) and 28% (2D). In non-glaucoma eyes, both 3D and 2D models showed higher predictability (R² 53%, optimism-corrected R² 45%), with final predictors incorporating AS-OCT anterior chamber area and iris thickness. Both 3D and 2D models significantly outperformed the reference preIOP models across all cohorts (all p > 0.05).

AS-OCT parameters improved the predictability of IOP reduction after phacoemulsification, with notably better performance in non-glaucoma eyes. 2D and 3D models showed comparable predictive ability.

## Linked entities

- **Diseases:** glaucoma (MONDO:0005041)

## Full-text entities

- **Genes:** CCT [NCBI Gene 907]
- **Diseases:** PAC (MESH:D015812), eyelid, corneal, or conjunctival abnormalities (MESH:D005141), lens subluxation (MESH:D007906), PAS (MESH:D006175), SS (MESH:D015422), trabecular (MESH:D000236), cataract (MESH:D002386), Glaucoma (MESH:D005901), ocular trauma (MESH:D014947), ACarea (MESH:C535679), glaucomatous eyes (MESH:D005134), intraocular inflammation (MESH:D007249), glaucomatous optic neuropathy (MESH:D009901), IOP (MESH:D064090), angle crowding (MESH:D008310), AOD (MESH:D005902), ocular hypertension (MESH:D009798)
- **Chemicals:** dexamethasone (MESH:D003907), AS (MESH:D001151), preIOP (-), steroid (MESH:D013256), tobramycin (MESH:D014031)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13016306/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13016306/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC13016306/full.md

---
Source: https://tomesphere.com/paper/PMC13016306